Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.

Saved in:
Bibliographic Details
Title: Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
Authors: Ding, Yiling1 (AUTHOR), Wang, Chunping2,3 (AUTHOR), Shu, Yamin1 (AUTHOR), Wang, Jinglin4 (AUTHOR) linlinvc202@163.com, Zhang, Qilin4 (AUTHOR) qilinzhang88@163.com
Source: Journal of Pharmaceutical Policy & Practice. Dec2025, Vol. 18 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190283053
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ding%2C+Yiling%22">Ding, Yiling</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Chunping%22">Wang, Chunping</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shu%2C+Yamin%22">Shu, Yamin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jinglin%22">Wang, Jinglin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> linlinvc202@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Qilin%22">Zhang, Qilin</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> qilinzhang88@163.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Pharmaceutical+Policy+%26+Practice%22">Journal of Pharmaceutical Policy & Practice</searchLink>. Dec2025, Vol. 18 Issue 1, p1-18. 18p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190283053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/20523211.2025.2464781
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 18
        StartPage: 1
    Titles:
      – TitleFull: Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ding, Yiling
      – PersonEntity:
          Name:
            NameFull: Wang, Chunping
      – PersonEntity:
          Name:
            NameFull: Shu, Yamin
      – PersonEntity:
          Name:
            NameFull: Wang, Jinglin
      – PersonEntity:
          Name:
            NameFull: Zhang, Qilin
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 20523211
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of Pharmaceutical Policy & Practice
              Type: main
ResultId 1